Data / Form D filings / C16 Biosciences, Inc.
C16 Biosciences, Inc.: Form D filings
C16 Biosciences, Inc., a biotechnology company in New York, NY, filed 4 Form D notices with the SEC between 2018 and 2023. The latest, on March 22, 2023, reports $5 million sold of a $10.2 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 619 W 54th Street, 7th Floor, New York, NY, 10019
- Phone
- (917) 983-6004
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1757728
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 22, 2023 | New notice | $10,244,013 | $4,984,415 | $5,259,598 | 17 | Feb 21, 2023 | sec.gov |
| Mar 11, 2020 | Amendment | $19,999,994 | $19,999,994 | 45 | Feb 14, 2020 | sec.gov | |
| Mar 3, 2020 | New notice | $19,999,994 | $19,999,994 | 45 | Feb 14, 2020 | sec.gov | |
| Nov 21, 2018 | New notice | $4,000,000 | $3,965,000 | $35,000 | 33 | Aug 16, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Harold McNamara | Director | |
| Shara Ticku | Executive Officer, Director, Promoter | |
| Peter Turner | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Mar 20, 2023 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what C16 Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.